$5.12 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 133 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 47.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | NUVALENT INC | $436,140,000 | – | 19,341,024 | +100.0% | 8.51% | – | |
| VTRS | VIATRIS INC | $255,065,000 | -5.2% | 18,824,000 | 0.0% | 4.98% | +4.2% | |
| INVITAE CORPnote 2.000% 9/0 | $199,645,000 | -9.9% | 163,385,000 | 0.0% | 3.90% | -1.0% | ||
| AHCO | Buy | ADAPTHEALTH CORP | $188,737,000 | -6.4% | 8,103,792 | +10.2% | 3.68% | +2.9% |
| CMAX | CAREMAX INC | $162,083,000 | -25.1% | 16,778,750 | 0.0% | 3.16% | -17.7% | |
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $143,842,000 | -8.2% | 157,390,000 | 0.0% | 2.81% | +0.9% | ||
| NATERA INCnote 2.250% 5/0 | $135,236,000 | -0.8% | 45,000,000 | 0.0% | 2.64% | +9.0% | ||
| Buy | GLAUKOS CORPnote 2.750% 6/1 | $129,642,000 | -15.6% | 108,000,000 | +20.0% | 2.53% | -7.2% | |
| BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $110,499,000 | -15.8% | 80,000,000 | 0.0% | 2.16% | -7.5% | ||
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $109,569,000 | +55.3% | 1,142,415 | +57.6% | 2.14% | +70.6% |
| ENVISTA HOLDINGS CORPORATIONnote 2.375% 6/0 | $109,205,000 | -2.5% | 52,500,000 | 0.0% | 2.13% | +7.1% | ||
| ORGO | Buy | ORGANOGENESIS HLDGS INC | $106,267,000 | -11.5% | 7,462,543 | +3.3% | 2.07% | -2.7% |
| New | SEMA4 HOLDINGS CORP | $105,110,000 | – | 13,848,488 | +100.0% | 2.05% | – | |
| OMIC | SINGULAR GENOMICS SYSTEMS IN | $101,963,000 | -59.3% | 9,112,019 | 0.0% | 1.99% | -55.3% | |
| NUVASIVE INCnote 0.01 6/0 | $98,794,000 | -2.5% | 96,966,000 | 0.0% | 1.93% | +7.2% | ||
| New | PACIRA BIOSCIENCES INCnote 0.750% 8/0 | $87,723,000 | – | 81,600,000 | +100.0% | 1.71% | – | |
| INSULET CORPnote 0.00375 9/0 | $80,407,000 | +2.8% | 57,581,000 | 0.0% | 1.57% | +13.0% | ||
| ISEE | Sell | IVERIC BIO INC | $78,987,000 | +117.0% | 4,863,725 | -15.7% | 1.54% | +138.7% |
| LUNG | Buy | PULMONX CORP | $73,035,000 | -8.1% | 2,029,887 | +12.7% | 1.42% | +1.0% |
| LRMR | LARIMAR THERAPEUTICS INC | $67,223,000 | +17.4% | 5,830,249 | 0.0% | 1.31% | +29.0% | |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $65,396,000 | +9.7% | 3,282,912 | -4.8% | 1.28% | +20.5% |
| EWTX | EDGEWISE THERAPEUTICS INC | $65,290,000 | -22.2% | 3,933,137 | 0.0% | 1.27% | -14.5% | |
| MOH | MOLINA HEALTHCARE INC | $62,883,000 | +7.2% | 231,776 | 0.0% | 1.23% | +17.8% | |
| CNC | Buy | CENTENE CORP DEL | $62,547,000 | -13.8% | 1,003,800 | +0.9% | 1.22% | -5.3% |
| INSMED INCnote 0.750% 6/0 | $55,120,000 | -0.7% | 50,000,000 | 0.0% | 1.08% | +9.1% | ||
| CYTK | Buy | CYTOKINETICS INC | $54,924,000 | +124.2% | 1,536,758 | +24.1% | 1.07% | +146.4% |
| SILK | Sell | SILK RD MED INC | $54,494,000 | +0.0% | 990,251 | -13.0% | 1.06% | +9.9% |
| PCRX | Sell | PACIRA BIOSCIENCES INC | $54,165,000 | -22.2% | 967,236 | -15.7% | 1.06% | -14.5% |
| Buy | NUVASIVE INCnote 0.00375 3/1 | $54,110,000 | +36.5% | 55,800,000 | +39.5% | 1.06% | +50.0% | |
| APR | Sell | APRIA INC | $52,668,000 | +19.6% | 1,417,700 | -9.9% | 1.03% | +31.5% |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $52,121,000 | +0.4% | 57,791,000 | 0.0% | 1.02% | +10.3% | ||
| INSMED INCnote 1.750% 1/1 | $51,712,000 | -1.5% | 50,000,000 | 0.0% | 1.01% | +8.1% | ||
| DFPH | DFP HEALTHCARE ACQUISITNS CO | $49,700,000 | -0.1% | 5,000,000 | 0.0% | 0.97% | +9.7% | |
| ATEC | Buy | ALPHATEC HLDGS INC | $43,821,000 | -15.9% | 3,594,829 | +5.7% | 0.86% | -7.7% |
| KURA | Buy | KURA ONCOLOGY INC | $43,368,000 | +15.9% | 2,315,417 | +29.1% | 0.85% | +27.4% |
| RVMD | REVOLUTION MEDICINES INC | $43,073,000 | -13.3% | 1,565,712 | 0.0% | 0.84% | -4.8% | |
| NATERA INCnote 2.250% 5/0 | $43,056,000 | -3.6% | 25,000,000 | 0.0% | 0.84% | +5.9% | ||
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $40,596,000 | +117.7% | 1,710,730 | +108.9% | 0.79% | +139.3% |
| VIVO | Buy | MERIDIAN BIOSCIENCE INC | $39,694,000 | +25.7% | 2,063,083 | +44.9% | 0.78% | +38.1% |
| KALV | KALVISTA PHARMACEUTICALS INC | $37,754,000 | -27.2% | 2,163,554 | 0.0% | 0.74% | -20.0% | |
| TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $37,450,000 | -17.9% | 45,000,000 | 0.0% | 0.73% | -9.9% | ||
| NUVB | NUVATION BIO INC | $35,558,000 | +6.8% | 3,577,233 | 0.0% | 0.69% | +17.2% | |
| Sell | APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $35,498,000 | -54.4% | 28,825,000 | -31.1% | 0.69% | -49.8% | |
| Buy | NEVRO CORP NOTE2.750% 4/0 | $34,876,000 | +67.2% | 26,000,000 | +116.7% | 0.68% | +83.6% | |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $33,938,000 | +156.7% | 2,977,020 | +260.4% | 0.66% | +181.7% |
| BKD | Buy | BROOKDALE SR LIVING INC | $33,093,000 | +27.0% | 5,252,800 | +59.3% | 0.65% | +39.5% |
| BDSI | Sell | BIODELIVERY SCIENCES INTL IN | $33,106,000 | -3.0% | 9,170,699 | -3.8% | 0.65% | +6.6% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $32,397,000 | -29.6% | 510,673 | -8.6% | 0.63% | -22.7% |
| HOWL | Sell | WEREWOLF THERAPEUTICS INC | $30,078,000 | -32.4% | 1,752,787 | -31.3% | 0.59% | -25.8% |
| GKOS | New | GLAUKOS CORP | $29,817,000 | – | 619,000 | +100.0% | 0.58% | – |
| ONCR | ONCORUS INC | $29,411,000 | -32.3% | 3,148,977 | 0.0% | 0.57% | -25.6% | |
| PHVS | Buy | PHARVARIS N V | $28,518,000 | +48.2% | 1,608,471 | +55.7% | 0.56% | +62.9% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $27,694,000 | -43.7% | 815,000 | -39.3% | 0.54% | -38.2% |
| INZY | Buy | INOZYME PHARMA INC | $27,176,000 | -26.8% | 2,344,786 | +7.6% | 0.53% | -19.7% |
| HEALTH CATALYST INCnote 2.500% 4/1 | $26,292,000 | -8.5% | 15,000,000 | 0.0% | 0.51% | +0.4% | ||
| RYTM | RHYTHM PHARMACEUTICALS INC | $25,985,000 | -33.3% | 1,989,625 | 0.0% | 0.51% | -26.7% | |
| XLRN | Sell | ACCELERON PHARMA INC | $24,955,000 | -9.4% | 145,000 | -33.9% | 0.49% | -0.4% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $24,702,000 | -59.6% | 1,394,000 | +2.3% | 0.48% | -55.6% |
| TERN | TERNS PHARMACEUTICALS INC | $24,445,000 | -15.0% | 2,345,959 | 0.0% | 0.48% | -6.7% | |
| ALEC | ALECTOR INC | $24,079,000 | +9.5% | 1,055,192 | 0.0% | 0.47% | +20.5% | |
| PMVP | PMV PHARMACEUTICALS INC | $23,959,000 | -12.8% | 804,000 | 0.0% | 0.47% | -4.1% | |
| KNTE | Buy | KINNATE BIOPHARMA INC | $23,676,000 | -0.3% | 1,028,508 | +0.8% | 0.46% | +9.5% |
| CGEM | CULLINAN ONCOLOGY INC | $23,563,000 | -12.3% | 1,044,000 | 0.0% | 0.46% | -3.8% | |
| AFIB | Sell | ACUTUS MED INC | $23,412,000 | -68.2% | 2,648,386 | -39.0% | 0.46% | -65.1% |
| VINC | New | VINCERX PHARMA INC | $22,303,000 | – | 1,379,310 | +100.0% | 0.44% | – |
| FATE | Buy | FATE THERAPEUTICS INC | $21,456,000 | -18.7% | 362,000 | +19.1% | 0.42% | -10.7% |
| ITMR | Sell | ITAMAR MED LTDsponsored ads | $20,993,000 | -25.3% | 694,667 | -41.8% | 0.41% | -17.8% |
| TIL | INSTIL BIO INC | $19,944,000 | -7.5% | 1,115,739 | 0.0% | 0.39% | +1.6% | |
| OM | OUTSET MED INC | $19,807,000 | -1.1% | 400,622 | 0.0% | 0.39% | +8.7% | |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $19,056,000 | -23.1% | 185,354 | -34.2% | 0.37% | -15.5% |
| PROF | PROFOUND MED CORP | $19,000,000 | -10.5% | 1,297,797 | 0.0% | 0.37% | -1.6% | |
| XERIS PHARMACEUTICALS INCnote 5.000% 7/1 | $18,864,000 | -33.9% | 18,000,000 | 0.0% | 0.37% | -27.4% | ||
| MAAC | New | MONTES ARCHIMEDES ACQUISITIO | $18,700,000 | – | 2,000,000 | +100.0% | 0.36% | – |
| GRAY | GRAYBUG VISION INC | $17,535,000 | -38.9% | 5,281,713 | 0.0% | 0.34% | -32.8% | |
| New | ERASCA INC | $16,693,000 | – | 786,660 | +100.0% | 0.33% | – | |
| LPTX | New | LEAP THERAPEUTICS INC | $16,040,000 | – | 4,000,000 | +100.0% | 0.31% | – |
| ORTX | ORCHARD THERAPEUTICS PLCads | $15,984,000 | -47.6% | 6,949,416 | 0.0% | 0.31% | -42.4% | |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $15,750,000 | -51.0% | 3,214,340 | -33.4% | 0.31% | -46.2% |
| New | DA32 LIFE SCNCE TEC ACQSTN C | $15,728,000 | – | 1,600,000 | +100.0% | 0.31% | – | |
| PTC THERAPEUTICS INC NOTE0.03 8/1 | $15,061,000 | -3.2% | 14,527,000 | 0.0% | 0.29% | +6.5% | ||
| AVTE | AEROVATE THERAPEUTICS INC | $14,986,000 | -8.1% | 714,285 | 0.0% | 0.29% | +0.7% | |
| GRPH | GRAPHITE BIO INC | $14,854,000 | -46.7% | 906,308 | 0.0% | 0.29% | -41.4% | |
| BCAB | Buy | BIOATLA INC | $13,669,000 | +31.4% | 464,300 | +89.2% | 0.27% | +44.3% |
| COGT | COGENT BIOSCIENCES INC | $13,464,000 | +3.7% | 1,601,000 | 0.0% | 0.26% | +13.9% | |
| SPRB | Buy | SPRUCE BIOSCIENCES INC | $13,222,000 | -42.4% | 2,200,000 | +7.5% | 0.26% | -36.8% |
| QSI | QUANTUM SI INC | $11,676,000 | -32.0% | 1,400,000 | 0.0% | 0.23% | -25.2% | |
| New | RXSIGHT INC | $11,403,000 | – | 900,000 | +100.0% | 0.22% | – | |
| New | TYRA BIOSCIENCES INC | $10,994,000 | – | 625,000 | +100.0% | 0.22% | – | |
| ANNX | ANNEXON INC | $10,867,000 | -17.3% | 583,913 | 0.0% | 0.21% | -9.0% | |
| New | DEFINITIVE HEALTHCARE CORP | $10,708,000 | – | 250,000 | +100.0% | 0.21% | – | |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $9,950,000 | -2.5% | 1,000,000 | 0.0% | 0.19% | +7.2% | |
| MTAC | New | MEDTECH ACQUISITION CORP | $9,930,000 | – | 999,999 | +100.0% | 0.19% | – |
| SRSAU | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $9,876,000 | -5.2% | 1,000,000 | 0.0% | 0.19% | +4.3% | |
| SNRH | New | SENIOR CONNECT ACQUISITN COR | $9,770,000 | – | 1,000,000 | +100.0% | 0.19% | – |
| REVH | New | REVOLUTION HEALTHCAR AQ CORP | $9,710,000 | – | 1,000,000 | +100.0% | 0.19% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INCput | $9,412,000 | – | 425,300 | +100.0% | 0.18% | – |
| New | CUE HEALTH INC | $9,435,000 | – | 798,867 | +100.0% | 0.18% | – | |
| AMWL | AMERICAN WELL CORPcl a | $9,029,000 | -27.6% | 991,115 | 0.0% | 0.18% | -20.4% | |
| GHRS | Sell | GH RESEARCH PLCordinary shares | $8,943,000 | -25.9% | 405,416 | -27.0% | 0.18% | -18.2% |
| New | NYXOAH S A | $8,797,000 | – | 300,800 | +100.0% | 0.17% | – | |
| AVAH | Sell | AVEANNA HEALTHCARE HLDGS INC | $8,124,000 | -67.2% | 1,013,007 | -49.3% | 0.16% | -63.8% |
| OLMA | OLEMA PHARMACEUTICALS INC | $7,474,000 | -1.5% | 271,191 | 0.0% | 0.15% | +8.1% | |
| TMPMU | TURMERIC ACQUISITION CORPunit 10/08/2025 | $7,448,000 | -1.3% | 750,000 | 0.0% | 0.14% | +8.2% | |
| IGNY | New | IGNYTE ACQUISITION CORP | $7,098,000 | – | 725,000 | +100.0% | 0.14% | – |
| PRVA | PRIVIA HEALTH GROUP INC | $7,068,000 | -46.9% | 300,000 | 0.0% | 0.14% | -41.5% | |
| CVRX | Buy | CVRX INC | $6,843,000 | -38.9% | 413,747 | +3.4% | 0.13% | -32.7% |
| BDTX | Sell | BLACK DIAMOND THERAPEUTICS I | $6,431,000 | -49.6% | 760,128 | -27.4% | 0.13% | -44.5% |
| RPHM | RENEO PHARMACEUTICALS INC | $6,327,000 | -20.2% | 849,300 | 0.0% | 0.12% | -12.8% | |
| BENEFITFOCUS INCnote 1.250%12/1 | $6,135,000 | +0.1% | 6,500,000 | 0.0% | 0.12% | +10.1% | ||
| CABA | CABALETTA BIO INC | $5,645,000 | +41.4% | 464,252 | 0.0% | 0.11% | +54.9% | |
| TPTX | TURNING POINT THERAPEUTICS I | $5,570,000 | -14.9% | 83,846 | 0.0% | 0.11% | -6.0% | |
| DCTH | DELCATH SYS INC | $5,220,000 | -17.2% | 500,000 | 0.0% | 0.10% | -8.9% | |
| OHPA | New | ORION ACQUISITION CORP | $4,850,000 | – | 500,000 | +100.0% | 0.10% | – |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $3,529,000 | – | 60,271 | +100.0% | 0.07% | – |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $3,372,000 | -92.5% | 234,643 | -91.7% | 0.07% | -91.7% |
| MDVL | MEDAVAIL HOLDINGS INC | $3,336,000 | -76.2% | 1,142,552 | 0.0% | 0.06% | -73.9% | |
| TALK | TALKSPACE INC | $2,738,000 | -56.1% | 750,000 | 0.0% | 0.05% | -52.3% | |
| NEOGENOMICS INCnote 0.250% 1/1 | $2,514,000 | +2.5% | 2,500,000 | 0.0% | 0.05% | +11.4% | ||
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $2,017,000 | -43.1% | 733,333 | 0.0% | 0.04% | -38.1% | |
| DFPHW | DFP HEALTHCARE ACQUISITNS CO*w exp 03/31/202 | $2,013,000 | -6.9% | 1,250,000 | 0.0% | 0.04% | +2.6% | |
| CMAXW | CAREMAX INC*w exp 06/08/202 | $1,900,000 | -40.1% | 672,000 | 0.0% | 0.04% | -33.9% | |
| MAACW | New | MONTES ARCHIMEDES ACQUISITIO*w exp 99/99/999 | $1,490,000 | – | 1,000,000 | +100.0% | 0.03% | – |
| MTCR | METACRINE INC | $952,000 | -9.7% | 277,469 | 0.0% | 0.02% | 0.0% | |
| QSIAW | QUANTUM SI INC*w exp 06/10/202 | $677,000 | -46.0% | 333,333 | 0.0% | 0.01% | -40.9% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $427,000 | -1.4% | 166,666 | 0.0% | 0.01% | 0.0% | |
| New | SOMALOGIC INC*w exp 03/01/202 | $414,000 | – | 120,000 | +100.0% | 0.01% | – | |
| SNRHW | New | SENIOR CONNECT ACQUISITN COR*w exp 12/31/202 | $355,000 | – | 500,000 | +100.0% | 0.01% | – |
| IGNYW | New | IGNYTE ACQUISITION CORP*w exp 01/05/202 | $232,000 | – | 362,500 | +100.0% | 0.01% | – |
| MTACW | New | MEDTECH ACQUISITION CORP*w exp 12/22/202 | $273,000 | – | 333,333 | +100.0% | 0.01% | – |
| New | SURROZEN INC*w exp 08/01/203 | $190,000 | – | 166,666 | +100.0% | 0.00% | – | |
| REVHW | New | REVOLUTION HEALTHCAR AQ CORP*w exp 12/31/202 | $186,000 | – | 200,000 | +100.0% | 0.00% | – |
| OHPAW | New | ORION ACQUISITION CORP*w exp 02/19/202 | $80,000 | – | 125,000 | +100.0% | 0.00% | – |
| WINT | WINDTREE THERAPEUTICS INC | $42,000 | -8.7% | 20,148 | 0.0% | 0.00% | 0.0% | |
| LUMO | Exit | LUMOS PHARMA INC | $0 | – | -33,117 | -100.0% | -0.01% | – |
| CEREW | Exit | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $0 | – | -166,666 | -100.0% | -0.04% | – |
| ACHL | Exit | ACHILLES THERAPEUTICS PLCsponsored ads | $0 | – | -301,431 | -100.0% | -0.05% | – |
| BMEA | Exit | BIOMEA FUSION INC | $0 | – | -248,447 | -100.0% | -0.07% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -255,456 | -100.0% | -0.08% | – |
| OHPAU | Exit | ORION ACQUISITION CORPunit 02/19/2026 | $0 | – | -500,000 | -100.0% | -0.09% | – |
| CHFWU | Exit | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $0 | – | -500,000 | -100.0% | -0.09% | – |
| INSM | Exit | INSMED INC | $0 | – | -200,000 | -100.0% | -0.10% | – |
| IGNYU | Exit | IGNYTE ACQUISITION CORPunit 01/05/2026 | $0 | – | -725,000 | -100.0% | -0.13% | – |
| GLUE | Exit | MONTE ROSA THERAPEUTICS INC | $0 | – | -350,000 | -100.0% | -0.14% | – |
| CMIIU | Exit | CM LIFE SCIENCES II INCunit 02/25/2028 | $0 | – | -600,000 | -100.0% | -0.14% | – |
| ADVM | Exit | ADVERUM BIOTECHNOLOGIES INC | $0 | – | -2,827,000 | -100.0% | -0.18% | – |
| MTACU | Exit | MEDTECH ACQUISITION CORPunit 12/18/2025 | $0 | – | -1,000,000 | -100.0% | -0.18% | – |
| REVHU | Exit | REVOLUTION HEALTHCAR AQ CORPunit 03/18/20266 | $0 | – | -1,000,000 | -100.0% | -0.18% | – |
| SNRHU | Exit | SENIOR CONNECT ACQUISITN CORunit 12/09/2023 | $0 | – | -1,000,000 | -100.0% | -0.18% | – |
| LFST | Exit | LIFESTANCE HEALTH GROUP INC | $0 | – | -400,000 | -100.0% | -0.20% | – |
| AGL | Exit | AGILON HEALTH INC | $0 | – | -300,000 | -100.0% | -0.22% | – |
| CNVY | Exit | CONVEY HLDG PARENT INC | $0 | – | -1,100,000 | -100.0% | -0.22% | – |
| BVS | Exit | BIOVENTUS INC | $0 | – | -778,567 | -100.0% | -0.24% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -560,132 | -100.0% | -0.25% | – |
| IMCR | Exit | IMMUNOCORE HLDGS PLCads | $0 | – | -360,966 | -100.0% | -0.25% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -1,816,221 | -100.0% | -0.26% | – |
| BLUE | Exit | BLUEBIRD BIO INC | $0 | – | -480,300 | -100.0% | -0.27% | – |
| DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -787,000 | -100.0% | -0.29% | – |
| JANX | Exit | JANUX THERAPEUTICS INC | $0 | – | -700,000 | -100.0% | -0.31% | – |
| STXS | Exit | STEREOTAXIS INC | $0 | – | -1,843,000 | -100.0% | -0.32% | – |
| MAACU | Exit | MONTES ARCHIMEDES ACQUISITIOunit 09/30/2025 | $0 | – | -2,000,000 | -100.0% | -0.38% | – |
| BHG | Exit | BRIGHT HEALTH GROUP INC | $0 | – | -1,400,000 | -100.0% | -0.43% | – |
| XERS | Exit | XERIS PHARMACEUTICALS INC | $0 | – | -6,553,398 | -100.0% | -0.47% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -2,941,492 | -100.0% | -0.50% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -3,811,554 | -100.0% | -0.51% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -3,769,795 | -100.0% | -0.62% | – |
| OMI | Exit | OWENS & MINOR INC NEW | $0 | – | -996,500 | -100.0% | -0.75% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -300,000 | -100.0% | -0.75% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -657,005 | -100.0% | -0.80% | – |
| Exit | CLOVIS ONCOLOGY INCnote 2.500% 9/1 | $0 | – | -49,064,000 | -100.0% | -0.85% | – | |
| QDEL | Exit | QUIDEL CORP | $0 | – | -409,219 | -100.0% | -0.93% | – |
| CNST | Exit | CONSTELLATION PHARMCETICLS I | $0 | – | -1,601,427 | -100.0% | -0.96% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -338,000 | -100.0% | -0.97% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.